05 American College of Allergy, Asthma and Immunology

[Guest guest]

Source: American College of Allergy, Asthma and Immunology

(ACAAI) Released: Fri 22-Jul-2005, 15:00 ET

http://www.newswise.com/articles/view/513327/

Printer-friendly Version

Register for " Vade Mecum " in Allergy, Asthma and Immunology

Libraries

Medical News Keywords

ALLERGY ASTHMA IMMUNOLOGY IMMUNOTHERAPY RHINOSINUSITIS FUNGI

Contact Information

Available for logged-in reporters only

Description

Journalists are invited to report on the latest developments in the

treatment of allergic diseases presented at the ACAAI Annual Meeting

in Anaheim, Nov. 4-9, 2005. The theme is " Vade Mecum " -- a concise

source of practical information and guidance you can take with you.

Newswise — Journalists are invited to report on the latest

developments in the treatment of allergic diseases including asthma

and immunologic disorders presented at the American College of

Allergy, Asthma and Immunology (ACAAI) Annual Meeting at the Anaheim

Convention Center, Nov. 4-9, 2005. The theme is " Vade Mecum " – a

concise source of practical information and guidance you can take

with you.

A pre-meeting " Rhinosinusitis Collegium " on Nov. 4 will be jointly

sponsored by the ACAAI and the European Academy of Allergology and

Clinical Immunology. Internationally known experts will discuss the

relationship of rhinosinusitis to IgE mediated allergy; nasal

polyposis and the asthma-aspirin connection; allergic fungal

sinusitis; the changing role of endoscopic sinus surgery; and

antibiotic and anti-inflammatory therapies.

Physicians, researchers and international experts will present and

discuss scientific data on conditions that afflict more than 50

million Americans, including the following topics:

~ Asthma in women: effects on life cycle changes and management

during pregnancy (Nov. 4)

~ Asthma in subpopulations: genetic variations, particulates and

viral infections (Nov. 4)

~ Allergen immunotherapy: sublingual vs. subcutaneous (Nov. 5)

~ The innate immune system: how it works and how it's related to

allergy (Nov. 5)

~ Preventing the atopic march: avoidance of allergens vs.

intentional exposure (Nov. 5)

~ Severe asthma: history, treatment options and economic analysis of

treatment cost (Nov. 6)

~ One linked airway: treatment of the upper airway and its impact on

the lower airway (Nov. 6)

~ Skin and mucosal diseases: management of cutaneous allergy

diseases (Nov. 7)

~ Primary immunodeficiency: diagnosis, common variable, clinical

clue (Nov. 7)

~ Asthma and COPD treatment: consensus and controversy (Nov. 8)

~ Socioeconomics: US Healthcare, electronic prescription writing,

and electronic medical records, and the significance of Black Box

Warnings (Nov. 8)

During a special half day intensive program on Nov. 9, " When Fungi

Aren't Fun, " experts will discuss mold-related allergic diseases,

mycotoxins, toxic molds and conducting air quality studies.

The Annual Meeting program consists of more than 115 scientific

sessions, 35 workshops, 350 technical exhibits and 250 abstract

presentations. The expected 4,000 meeting participants include some

1,700 physicians, 200 allied health professionals, 100 office

managers and 1,200 pharmaceutical representatives.

The preliminary program and downloadable housing and registration

forms are online at www.acaai.org/Member. All media attending the

meeting must present credentials to register for an ACAAI Press

Badge for free access to educational programs.

The ACAAI is a professional medical organization, headquartered in

Arlington Heights, Ill., comprising nearly 5,000 qualified

allergists-immunologists and related health care professionals. The

College is dedicated to the clinical practice of allergy, asthma and

immunology through education and research to promote the highest

quality of patient care.

---------------------------------------------------------------------

-----------